Reports
Sale
Global Hemodialysis Vascular Grafts Market Share: By Product: Synthetic Grafts, Biological Grafts; By Diameters: Small Diameter Grafts (4 to 6 mm), Large Diameter Grafts (6 to 10 mm); By Configuration: Straight Grafts, Loop Grafts; By End Use: Hospitals, Dialysis Centers, Others; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Hemodialysis Vascular Grafts Market Outlook
The global hemodialysis vascular grafts market size was valued at USD 284.78 million in 2023, driven by the increasing geriatric population across the globe. The market size is anticipated to grow at a CAGR of 5.2% during the forecast period of 2024-2032 to achieve a value of USD 449.41 million by 2032.
Hemodialysis Vascular Grafts: Introduction
Arteriovenous (AV) graft is widely used for hemodialysis. The usual placement of graft is in the arm, but it can also be placed in the leg depending upon the situation. An AV graft is the connection of a vein and an artery that utilizes a hollow, synthetic tube (the actual “graft”). This connection enables high blood flow, high pressure artery through the graft and into the low flow, low pressure vein. Due to which, blood flow through the graft provides a flow rate delivering sufficient blood to provide an appropriate hemodialysis treatment.
Global Hemodialysis Vascular Grafts Market Analysis
The market for hemodialysis vascular grafts has been experiencing significant growth supported by various factors and is expected to steadily grow in coming years as well. The factors such as increasing technological advancement in hemodialysis therapy are majorly influencing the market growth. The advancements such as bioartificial kidneys, hemodiafiltration, wearable artificial kidneys, and portable machines are influencing the market and hemodialysis adoption by patients and healthcare professionals.
The key players are heavily investing in the research and development activities that are inclined towards creating more advanced technological equipment, medicinal drugs and therapies to treat chronic kidney diseases which is expected to further propel the global hemodialysis vascular grafts market growth. For example, Kidney Health Initiative and Kidney X: The Kidney Innovation Accelerator, as well as The Advancing American Kidney Health Initiative are collaborating to develop new therapies which could potentially customize the treatment of end-stage renal disease ESRD. The continuous research and development activities by key players in the market are directly contributing to the market expansion as well. For example, Xeltis is a key player targeted towards developing transformative implants to provide solutions to the patients of such chronic diseases has presented highly encouraging six-month data from its first-in-human (FIH) aXess vascular graft trial (NCT04898153). The data exhibited high patency rates (80% primary patency, 95% primary assisted patency, 100% secondary patency). A 0% infection rate and low re-intervention rates were encountered at the six months duration, resulting in a highly favorable safety profile.
Global Hemodialysis Vascular Grafts Market Segmentations
Market Breakup by Product
- Synthetic Grafts
- Expanded Polytetrafluoroethylene (ePTFE)
- Polyethylene Terephthalate (PET)
- Biological Grafts
- Human Saphenous and Umbilical Veins
- Autologous Vein Grafts
- Bovine Grafts
- Porcine Grafts
- Others
Market Breakup by Diameters
- Small Diameter Grafts (4 to 6 mm)
- Large Diameter Grafts (6 to 10 mm)
Market Breakup by Configuration
- Straight Grafts
- Loop Grafts
Market Breakup by End Use
- Hospitals
- Dialysis Centers
- Ambulatory Surgical Centers (ASCs)
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Hemodialysis Vascular Grafts Market Overview
The increasing prevalence of chronic kidney diseases worldwide is propelling the market growth. According to the National Kidney Foundation, nearly 10% of the global population is affected by chronic kidney disease (CKD) accounting for millions of deaths yearly. The increase in geriatric population globally is also a major factor, adding further growth to the global hemodialysis vascular grafts market share. With increasing age, people get more susceptible to kidney diseases due to various factors, such as cardiovascular diseases, hypertension, and diabetes, among others.
North America has been leading the global market and is expected to lead the global market for the forecast period as well. This growth of the region is expected to be driven by the presence of geriatric population, large patient pool suffering from chronic kidney diseases due to factors such as adoption of sedentary lifestyle, including alcohol consumption, and unhealthy dietary habits, among others.
Hemodialysis Vascular Grafts Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- W. L. Gore & Associates, Inc.,
- C. R. Bard, Inc.
- Vascudyne, Inc.
- LeMaitre
- Getinge AB,
- VASCULAR GENESIS,
- InnAVasc Medical, Inc.
- CryoLife, Inc.
- Merit Medical Systems
- BIOVIC Sdn Bhd.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Diameters |
|
| Breakup by Configuration |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hemodialysis Vascular Grafts Market Overview
3.1 Global Hemodialysis Vascular Grafts Market Historical Value (2017-2023)
3.2 Global Hemodialysis Vascular Grafts Market Forecast Value (2024-2032)
4 Global Hemodialysis Vascular Grafts Market Landscape
4.1 Global Hemodialysis Vascular Grafts Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hemodialysis Vascular Grafts Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Diameter
4.2.3 Analysis by Configuration
5 Global Hemodialysis Vascular Grafts Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hemodialysis Vascular Grafts Market Segmentation
6.1 Global Hemodialysis Vascular Grafts Market by Product
6.1.1 Market Overview
6.1.2 Synthetic Grafts
6.1.2.1 Expanded Polytetrafluoroethylene (ePTFE)
6.1.2.2 Polyethylene Terephthalate (PET)
6.1.3 Biological Grafts
6.1.3.1 Human Saphenous and Umbilical Veins
6.1.3.2 Autologous Vein Grafts
6.1.3.3 Bovine Grafts
6.1.3.4 Porcine Grafts
6.1.3.5 Others
6.2 Global Hemodialysis Vascular Grafts Market by Diameters
6.2.1 Market Overview
6.2.2 Small Diameter Grafts (4 to 6 mm)
6.2.3 Large Diameter Grafts (6 to 10 mm)
6.3 Global Hemodialysis Vascular Grafts Market by Configuration
6.3.1 Market Overview
6.3.2 Straight Grafts
6.3.3 Loop Grafts
6.4 Global Hemodialysis Vascular Grafts Market by End Use
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Dialysis Centers
6.4.4 Ambulatory Surgical Centers (ASCs)
6.4.5 Others
6.5 Global Hemodialysis Vascular Grafts Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Hemodialysis Vascular Grafts Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Hemodialysis Vascular Grafts Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Hemodialysis Vascular Grafts Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Hemodialysis Vascular Grafts Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Hemodialysis Vascular Grafts Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 W. L. Gore & Associates, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 C. R. Bard, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Vascudyne, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 LeMaitre
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Getinge AB
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 VASCULAR GENESIS
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 InnAVasc Medical, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 CryoLife, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Merit Medical Systems
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 BIOVIC Sdn Bhd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Hemodialysis Vascular Grafts Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 284.78 million in 2023, driven by the increasing geriatric and paediatric patient pool.
The market is anticipated to grow at a CAGR of 5.2% during the forecast period of 2024-2032, likely to reach a market value of USD 449.41 billion by 2032.
The increasing geriatric population across the globe is a major factor driving the demand for the market.
The increasing number of studies and investments by key players in the market are major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products available in the market include synthetic grafts and biological grafts.
The diameters are small diameter grafts (4 to 6 mm) and large diameter grafts (6 to 10 mm).
They come as straight grafts and loop grafts.
The end users in the market include hospitals, dialysis centers, ambulatory surgical centers (ASCS), among others.
Key players involved in the market are W. L. Gore & Associates, Inc., C. R. Bard, Inc., Vascudyne, Inc., LeMaitre, Getinge AB, VASCULAR GENESIS, InnAVasc Medical, Inc., CryoLife, Inc., BIOVIC Sdn Bhd., and Merit Medical Systems.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER